18270703

Source:http://linkedlifedata.com/resource/pubmed/id/18270703

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0021760, umls-concept:C0144576, umls-concept:C0441655, umls-concept:C0442874
pubmed:issue	6
pubmed:dateCreated	2008-9-15
pubmed:abstractText	This study was conducted to investigate the potential neuroprotective effect of IL-6 on chemotherapy induced neuropathy (CIN). IL-6 was compared to four-methylcatechol (4-MC)-a known inducer of NGF secretion previously shown to exhibit neuroprotective effects in CIN models.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7806519
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/4-methylcatechol, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Catechols, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Interleukin-6, http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents, http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1432-0843
pubmed:author	pubmed-author:AndriambelosonEmileE, pubmed-author:CallizotNoelleN, pubmed-author:CirilloRoccoR, pubmed-author:DreanoMichelM, pubmed-author:FerroPamelaP, pubmed-author:GlassJonathanJ, pubmed-author:RevelMichelM, pubmed-author:VittePierre-AlainPA
pubmed:issnType	Electronic
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	995-1007
pubmed:meshHeading	pubmed-meshheading:18270703-Adenocarcinoma, pubmed-meshheading:18270703-Aged, pubmed-meshheading:18270703-Animals, pubmed-meshheading:18270703-Antineoplastic Agents, pubmed-meshheading:18270703-Ataxia, pubmed-meshheading:18270703-Catechols, pubmed-meshheading:18270703-Cisplatin, pubmed-meshheading:18270703-Colonic Neoplasms, pubmed-meshheading:18270703-Drug Evaluation, Preclinical, pubmed-meshheading:18270703-Female, pubmed-meshheading:18270703-Humans, pubmed-meshheading:18270703-Interleukin-6, pubmed-meshheading:18270703-Mice, pubmed-meshheading:18270703-Mice, Inbred BALB C, pubmed-meshheading:18270703-Mice, Inbred C57BL, pubmed-meshheading:18270703-Neural Conduction, pubmed-meshheading:18270703-Neuroprotective Agents, pubmed-meshheading:18270703-Paclitaxel, pubmed-meshheading:18270703-Pain Threshold, pubmed-meshheading:18270703-Peripheral Nervous System Diseases, pubmed-meshheading:18270703-Postural Balance, pubmed-meshheading:18270703-Rats, pubmed-meshheading:18270703-Rats, Inbred Strains, pubmed-meshheading:18270703-Transplantation, Heterologous, pubmed-meshheading:18270703-Vincristine
pubmed:year	2008
pubmed:articleTitle	Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.
pubmed:affiliation	Neurofit, rue Jean Sapidus, Parc d'Innovation, 67400, Illkirch, France. noelle.callizot@gmail.com
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't